Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct

This publication has 108 references indexed in Scilit:

• Mass Spectrometry-Based Screening for Inhibitors of β-Amyloid Protein Aggregation
  Analytical Chemistry, 2005
• Structural properties of Aβ protofibrils stabilized by a small molecule
  Proceedings of the National Academy of Sciences, 2005
• Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
  Journal of Biological Chemistry, 2005
• Conformation-dependent antibodies target diseases of protein misfolding
  Trends in Biochemical Sciences, 2004
• Protein folding and misfolding
  Nature, 2003
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
  Science, 2003
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
  Nature, 2002
• Inhibition of Alzheimer's disease β‐amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy
  The FASEB Journal, 2001
• Selective Inhibition of Aβ Fibril Formation
  Journal of Biological Chemistry, 1996
• Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro
  Biochemical and Biophysical Research Communications, 1994